In the last year we have seen the publication of multiple guidance documents on the management of heart failure, each setting new standards for the management of HFpEF, including two national guidelines and a consensus statement on the phenotyping of HFpEF. Why do we need so many guidance documents? What was the rationale behind their development? And how concordant are they?
In the final episode of Heart Failure in Focus for 2023, Dr Muthiah Vaduganathan is joined by Prof Giuseppe Rosano (St George’s Hospital London, UK), who played a central part in the development of the 2023 European heart failure guideline focussed update and an earlier publication on HFpEF phenotyping. He shares his thoughts on these aforementioned questions and together with our host, provide a practical interpretation of how to incorporate the three distinct documents into daily practice.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
All content for Heart Failure in Focus is the property of Radcliffe Cardiology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the last year we have seen the publication of multiple guidance documents on the management of heart failure, each setting new standards for the management of HFpEF, including two national guidelines and a consensus statement on the phenotyping of HFpEF. Why do we need so many guidance documents? What was the rationale behind their development? And how concordant are they?
In the final episode of Heart Failure in Focus for 2023, Dr Muthiah Vaduganathan is joined by Prof Giuseppe Rosano (St George’s Hospital London, UK), who played a central part in the development of the 2023 European heart failure guideline focussed update and an earlier publication on HFpEF phenotyping. He shares his thoughts on these aforementioned questions and together with our host, provide a practical interpretation of how to incorporate the three distinct documents into daily practice.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Join us for our second podcast in the series where our host Dr Muthiah Vaduganathan continues the theme of SGLT-2 inhibitors in heart failure. This month’s guest is Prof Carolyn Lam who, together with Muthu will be answering your questions about SGLT-2 inhibitors and the practical management of heart failure patients.
All of the questions answered in this podcast have been submitted by real practitioners who manage heart failure on a daily basis, so there’s every chance that if you’ve had a burning question on this topic, Muthu and Carolyn will be answering it. These wide ranging questions cover themes across the practical use of SGLT-2 inhibitors such as the use of diuretics, choosing between different SGLT-2 inhibitors and their use in specific patient sub-groups, to the methodology and results of the recent DELIVER trial and other trials in HFpEF patients.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Heart Failure in Focus
In the last year we have seen the publication of multiple guidance documents on the management of heart failure, each setting new standards for the management of HFpEF, including two national guidelines and a consensus statement on the phenotyping of HFpEF. Why do we need so many guidance documents? What was the rationale behind their development? And how concordant are they?
In the final episode of Heart Failure in Focus for 2023, Dr Muthiah Vaduganathan is joined by Prof Giuseppe Rosano (St George’s Hospital London, UK), who played a central part in the development of the 2023 European heart failure guideline focussed update and an earlier publication on HFpEF phenotyping. He shares his thoughts on these aforementioned questions and together with our host, provide a practical interpretation of how to incorporate the three distinct documents into daily practice.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
